OCULAR THERAPEUTIX, INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ocular Therapeutix, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q2 2024.
  • Ocular Therapeutix, Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11.3M, a 156% increase year-over-year.
  • Ocular Therapeutix, Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $28.1M, a 61% increase year-over-year.
  • Ocular Therapeutix, Inc annual Share-based Payment Arrangement, Expense for 2023 was $17.8M, a 5.08% increase from 2022.
  • Ocular Therapeutix, Inc annual Share-based Payment Arrangement, Expense for 2022 was $17M, a 13.3% increase from 2021.
  • Ocular Therapeutix, Inc annual Share-based Payment Arrangement, Expense for 2021 was $15M, a 98.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $28.1M $11.3M +$6.88M +156% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $21.2M $7.98M +$3.41M +74.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $17.8M $4.33M +$94K +2.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $17.7M $4.51M +$272K +6.42% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $17.5M $4.41M +$132K +3.08% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $17.3M $4.57M +$363K +8.62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $17M $4.23M +$392K +10.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $16.6M $4.24M +$482K +12.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $16.1M $4.28M -$11K -0.26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $16.1M $4.21M +$1.12M +36.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $15M $3.84M +$1.74M +82.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 $13.2M $3.76M +$1.82M +94.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $11.4M $4.29M +$2.47M +135% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $8.95M $3.09M +$1.42M +85.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $7.53M $2.1M +$151K +7.73% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $7.38M $1.94M -$1.23M -38.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $8.61M $1.83M +$131K +7.73% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $8.48M $1.67M -$277K -14.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $8.76M $1.95M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $3.17M +$1.3M +69.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.7M -$135K -7.38% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.94M +$111K +6.06% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 $1.87M +$122K +6.97% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.83M +$73K +4.16% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.83M +$126K +7.39% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $1.75M +$382K +27.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.76M +$242K +16% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.71M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q3 2016 $1.37M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $1.52M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q3 2014 $607K +$486K +402% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $557K +$436K +360% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-29
Q3 2013 $121K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $121K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.